GALWAY, Ireland--(BUSINESS WIRE)--Following months of collaborative development work, Aerogen ® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin ...

GALWAY, Ireland--(BUSINESS WIRE)--Swedish based Maquet Critical Care and Aerogen, Ireland, have today announced the release of their partnered product, an integrated unit which provides state of ...

Cansino Biologics Inc. has entered a development and commercial supply partnership with Aerogen Ltd. for an inhalable version of its COVID-19 vaccine, Convidecia, also known as Ad5-nCoV. Cansino will ...

After months of collaborative work in the lab, China's CanSino Biologics and Irish drug delivery specialist Aerogen are taking their inhaled COVID-19 vaccine pact to the next stage. CanSino and ...

GALWAY, Ireland and OBERHACHING, Germany, Dec. 7, 2017 /PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Lyomark Pharma, an ...

AeroGen Inc. settled a contract dispute with Becton Dickinson & Co. by paying $2 million for exclusive rights to patents for insulin inhalers. AeroGen, which makes products to control the delivery ...

Aerogen's Head of Legal and Tax Deirdre O'Grady with CEO John Power. Photo: Maxwells/PA Wire An Irish medical-tech firm which created a ground-breaking vaccine by inhaler is set to double its ...

Following months of collaborative development work, Aerogen ® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial supply ...